PART A: DRUG INTERACTION STUDY OF SOFOSBUVIR AND ANTIRETROVIRAL THERAPY (ART) COMBINATIONS IN HIV AND HEPATITIS C VIRUS (HCV) CO-INFECTED PATIENTS. PART B: EFFICACY AND SAFETY OF SOFOSBUVIR FOR 12 WEEKS IN HIV/HCV CO-INFECTED PATIENTS.: